[Targeted drug delivery system: potential application to resveratrol]

Area of Science:

• Nanotechnology
• Pharmaceutical Sciences
• Pharmacology

Background:

• Drug delivery systems (DDS) aim to improve drug efficacy and reduce side effects through targeted distribution.
• Resveratrol, a phytochemical with significant therapeutic potential, suffers from poor bioavailability due to its complex pharmacokinetic profile.
• Nanotechnology offers novel approaches to overcome these limitations for resveratrol.

Purpose of the Study:

• To review the fundamental principles of nanotechnology applied to DDS.
• To present current research on nanotechnology-based formulations of resveratrol.
• To highlight key areas for future investigations in this field.

Main Methods:

• Review of existing literature on nanotechnology for DDS.
• Focus on resveratrol as a model compound.
• Analysis of in vitro and in vivo studies using various nanoparticle systems (liposomes, solid lipid nanoparticles, cyclodextrins, micelles).

Main Results:

• Nanoparticle formulations, including liposomes, solid lipid nanoparticles, cyclodextrins, and micelles, are being investigated to improve resveratrol's pharmacokinetic profile.
• These advanced DDS show promise in enhancing the effectiveness of resveratrol.
• Current research indicates potential for targeted delivery and reduced adverse effects.

Conclusions:

• Nanotechnology provides innovative strategies for developing advanced drug delivery systems.
• Novel resveratrol formulations utilizing nanoparticles demonstrate potential for improved therapeutic outcomes.
• Further research is crucial to fully realize the potential of nanotechnology in enhancing resveratrol's delivery and efficacy.